KEYZELL
Contact information
Keyzell Holding, S.L.
José del Corral - CEO
Avenida de la Aeronáutica, 10, planta 7, puerta 3
Sevilla, C.P. 41020
Sevilla
+34 620 473 830
Areas of activities
- Diagnostic imaging
- Screening
- Oncology
- Bioinformatics
Commissions
KeyZell is a bio-pharmaceutical company established in 2020 with subsidiaries in the United Kingdom, Australia, Thailand, and Mexico. Our primary goal is to bring a frontline molecule to market for cancer treatment, alongside two artificial intelligence-based platforms for cancer combat.
Products and services
- LZ 167 (peptide)
- OPS (Oncology Precision System AI)
- ODS (Oncology Diagnosis System AI)
Areas of interest for future collaborations
Regenerative Therapies, and Stem Cells.